The market is dominated by foreign suppliers, as imports account for 82.0% of total market size in 2022. B2B drives market demand, with B2B spending representing 51.8% of total demand in 2022. Italy has the fifth largest market size for pharmaceuticals regionally, with demand reaching USD44.7 billion in 2022. Eli Lilly Italia SpA is the largest company in Italy, generating 7.7% of the industry’s total production value in 2022. The industry is fragmented, with the top five companies generating 26.3% of total production value in 2022. The total number of companies decreases in 2022, to 1,863 units. The costs of the industry increase by 4.9% in 2022, largely driven by rising B2B costs. The industry’s profitability decreases and stands at 11.7% of production value in 2022, the 18th highest regionally. The industry’s exports share increases in 2022 to 81.7% of total production output. With production value of USD36.1 billion, Italy accounts for 6.2% of the Western Europe total in 2022.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF.
This Euromonitor industrial report provides unique information on Pharmaceuticals in Italy: ISIC 2423. With this industrial report, you’ll be able to explore the industry from its sources of supply to its buyers. The Pharmaceuticals in Italy: ISIC 2423 report includes: Industry datagraphics including production data, exports, imports, cost structure, and profitability
Pharmaceuticals and Medical Equipment is an aggregation of Pharmaceuticals, Medical and Surgical Equipment.
See All of Our DefinitionsIf you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!